Sorry, you need to enable JavaScript to visit this website.

PRISTIQ® (desvenlafaxine succinate) How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

PRISTIQ® (desvenlafaxine) extended-release tablets are available as follows:

25 mg, tan, square pyramid tablet debossed with "W" (over) "25" on the flat side

 
NDC 0008-1210-30, bottle of 30 tablets in unit-of-use package

50 mg, light pink, square pyramid tablet debossed with "W" (over) "50" on the flat side

 
NDC 0008-1211-14, bottle of 14 tablets in unit-of-use package
 
NDC 0008-1211-30, bottle of 30 tablets in unit-of-use package
 
NDC 0008-1211-01, bottle of 90 tablets in unit-of-use package
 
NDC 0008-1211-50, 10 blisters of 10 (HUD)

100 mg, reddish-orange, square pyramid tablet debossed with "W" (over) "100" on the flat side

 
NDC 0008-1222-14, bottle of 14 tablets in unit-of-use package
 
NDC 0008-1222-30, bottle of 30 tablets in unit-of-use package
 
NDC 0008-1222-01, bottle of 90 tablets in unit-of-use package
 
NDC 0008-1222-50, 10 blisters of 10 (HUD)

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

Each tablet contains 38 mg, 76 mg or 152 mg of desvenlafaxine succinate equivalent to 25 mg, 50 mg or 100 mg of desvenlafaxine, respectively.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No